SEC Form 4 · accession 0001209191-15-027433
ORAGENICS INC · OGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles L Pope
Director
Period of report
Mar 16, 2015
Accepted (ET)
Mar 18, 2015 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001174940
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 16, 2015 | A | 40,000 | $0.00 | A | 161,063 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Director Option (Right to Buy)F2 | $1.32 | Mar 16, 2015 | A | 80,000 | A | Mar 16, 2016 | Mar 16, 2025 | Common Stock | 80,000 | 80,000 | D |
Explanation of responses
- F1Represents an award of restricted stock in connection with service to the Company pursuant to the 2012 Equity Incentive Plan that vests equally over each of the four calendar quarters during 2015.
- F2Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, that vest equally over three years commencing on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, March 16, 2015.